Teligent Gross Profit 2010-2021 | TLGT
Teligent gross profit from 2010 to 2021. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
Teligent Annual Gross Profit
(Millions of US $) |
| 2020 |
$-4 |
| 2019 |
$24 |
| 2018 |
$22 |
| 2017 |
$27 |
| 2016 |
$35 |
| 2015 |
$21 |
| 2014 |
$17 |
| 2013 |
$6 |
| 2012 |
$3 |
| 2011 |
$2 |
| 2010 |
$1 |
| 2009 |
$0 |
Teligent Quarterly Gross Profit
(Millions of US $) |
| 2021-06-30 |
$-3 |
| 2021-03-31 |
$-1 |
| 2020-12-31 |
$-5 |
| 2020-09-30 |
$0 |
| 2020-06-30 |
$3 |
| 2020-03-31 |
$-1 |
| 2019-12-31 |
$2 |
| 2019-09-30 |
$7 |
| 2019-06-30 |
$9 |
| 2019-03-31 |
$6 |
| 2018-12-31 |
$6 |
| 2018-09-30 |
$7 |
| 2018-06-30 |
$5 |
| 2018-03-31 |
$5 |
| 2017-12-31 |
$4 |
| 2017-09-30 |
$3 |
| 2017-06-30 |
$10 |
| 2017-03-31 |
$11 |
| 2016-12-31 |
$9 |
| 2016-09-30 |
$8 |
| 2016-06-30 |
$10 |
| 2016-03-31 |
$8 |
| 2015-12-31 |
$6 |
| 2015-09-30 |
$6 |
| 2015-06-30 |
$4 |
| 2015-03-31 |
$6 |
| 2014-12-31 |
$8 |
| 2014-09-30 |
$3 |
| 2014-06-30 |
$3 |
| 2014-03-31 |
$3 |
| 2013-12-31 |
$3 |
| 2013-09-30 |
$1 |
| 2013-06-30 |
$1 |
| 2013-03-31 |
$1 |
| 2012-12-31 |
$1 |
| 2012-09-30 |
$1 |
| 2012-06-30 |
$1 |
| 2012-03-31 |
$0 |
| 2011-12-31 |
$1 |
| 2011-09-30 |
$1 |
| 2011-06-30 |
$1 |
| 2011-03-31 |
$0 |
| 2010-12-31 |
$1 |
| 2010-09-30 |
$0 |
| 2010-06-30 |
$0 |
| 2010-03-31 |
$-0 |
| 2009-12-31 |
$-0 |
| 2009-09-30 |
$0 |
| 2009-06-30 |
$0 |
| 2009-03-31 |
$-0 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.000B |
$0.000B |
|
Teligent, Inc. is a specialty generic pharmaceutical company, develops, manufactures and markets topical formulations primarily in the United States. It sells generic pharmaceutical products in topical, injectable, complex and ophthalmic dosage forms. Teligent Inc., formerly known as IGI Laboratories, Inc., is based in Buena, New Jersey.
|
